Language selection

Search

Details for: SANDOZ QUETIAPINE XRT

Company: SANDOZ CANADA INCORPORATED

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02407671SANDOZ QUETIAPINE XRTQUETIAPINE (QUETIAPINE FUMARATE)50 MGTABLET (EXTENDED-RELEASE)ORAL
02407698SANDOZ QUETIAPINE XRTQUETIAPINE (QUETIAPINE FUMARATE)150 MGTABLET (EXTENDED-RELEASE)ORAL
02407701SANDOZ QUETIAPINE XRTQUETIAPINE (QUETIAPINE FUMARATE)200 MGTABLET (EXTENDED-RELEASE)ORAL
02407728SANDOZ QUETIAPINE XRTQUETIAPINE (QUETIAPINE FUMARATE)300 MGTABLET (EXTENDED-RELEASE)ORAL
02407736SANDOZ QUETIAPINE XRTQUETIAPINE (QUETIAPINE FUMARATE)400 MGTABLET (EXTENDED-RELEASE)ORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Urinary Retention
Summary Safety Review - Atypical Antipsychotics - Liver failure
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: